Activity and safety of the antiestrogen EM-800, the orally active precursor of acolbifene, in tamoxifen-resistant breast cancer

R. M. Elledge, Richard M. Elledge

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Activity and safety of the antiestrogen EM-800, the orally active precursor of acolbifene, in tamoxifen-resistant breast cancer'. Together they form a unique fingerprint.